ClinicalTrials.Veeva

Menu

Immune Function Following Liver Transplantation (SEPTIFOIE)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Liver Transplant; Complications

Treatments

Genetic: Biological testing on sequential blood sample

Study type

Observational

Funder types

Other

Identifiers

NCT04302246
NI 11055

Details and patient eligibility

About

Post-operative care following liver transplantation is characterized by a high incidence of infective and immunological complications. Restauration of liver function following liver transplantation is progressive and characterize a period of immuno-infective vulnerability. The purpose of this study is to characterize the early post-operative immune function in children after liver transplantation.

Full description

Within a few decades, liver transplantation has become an effective treatment of end-stage liver diseases associated with high spontaneous mortality. However, the consequences of immediate transplants are frequently complicated by infective (nosocomial infection) and immunological complications (acute graft rejection) in up to 40 to 60% of liver transplanted patients. In order to ensure graft immunotolerance, immunosuppressive therapy based mainly on calcineurin inhibitors, is initiated soon after liver transplantation. Immunosuppressive therapy is intended to reduce the response of cytotoxic lymphocytes and NK cells. As a result, an important component of the immune response is blocked. In addition, function of the transplanted liver, which is a key organ for both immuno-inflammatory signalling and host defense against pathogens, is progressively restored post-operatively. Thus in this post-transplant period, there is a critical period where liver function is severly impaired and progressively get restaured. The aim of this study is to characterize the restauration of immune function in the early post-operative period and evaluate its correlation with occurence of infective or immunological complications.

Enrollment

61 patients

Sex

All

Ages

1 day to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Child under 18 admitted for liver transplantation
  • Signature of consent by the two holders of parental authority.
  • Informing children as far as their age and condition allow.
  • Affiliation to a social protection

Exclusion criteria

  • Children under 6 kg
  • Children transplanted for primary graft dysfunction
  • Children scheduled for liver-kidney transplants

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems